Prescription for Profit: Pharmaceutical-Biotech Industry's 2016 Outlook, an Industrial Info News Alert
(firmenpresse) - SUGAR LAND, TX -- (Marketwired) -- 02/29/16 -- Researched by Annette Kreuger, Global VP Pharmaceutical-Biotech Group, Industrial Info Resources (Sugar Land, Texas) -- With current economic reports going from bad to worse, the shines a strong ray of economic light. Despite the roller coaster rise and fall of the economic scene, the fact remains that a successful drug that the public either needs or desires, requires the facilities to develop, test, produce, package and distribute it. The epic rate of new drug approvals -- paired with an ever expanding client base -- is helping to fuel the growth in facilities across the globe.
Industrial Info is tracking this growth with the launch of its global reporting in the Pharmaceutical-Biotech Industry. In North America alone, the world's largest market for drug products, the industry is set to launch more than $20 billion in capital projects during 2016. Globally, that number increases by a minimum of $10 billion. Ranging from $1 million to nearly $2 billion per project, today's industry project-spending activity is rivaling the "golden years" of pharma.
No matter what part of the region one looks in, there is a major industry project on tap. Manufacturing of active pharmaceuticals ingredients (APIs) is hot across the globe again, thanks to both expanded demand and new drug products. The bulk of drug development still occurs in the West, led by the U.S.
To read the complete story, check out the most recent edition of Industrial Info's , which includes details on the declining project fallout in North America; the Transmission Industry's crowded schedule for the coming years; and upcoming tradeshows and event featuring Industrial Info's top researchers.
Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "" page.
Contact:
William Ploch
713-783-5147
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 29.02.2016 - 11:30 Uhr
Sprache: Deutsch
News-ID 453817
Anzahl Zeichen: 0
contact information:
Town:
SUGAR LAND, TX
Kategorie:
Specialty Chemicals
Diese Pressemitteilung wurde bisher 461 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Prescription for Profit: Pharmaceutical-Biotech Industry's 2016 Outlook, an Industrial Info News Alert"
steht unter der journalistisch-redaktionellen Verantwortung von
Industrial Info Resources (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
